Gene therapy for neovascular age-related macular degeneration: rationale, clinical trials and future directions | British Journal of Ophthalmology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

XML

Review

Gene therapy for neovascular age-related macular degeneration: rationale, clinical trials and future directions

Online download statistics by month:

Online download statistics by month: April 2020 to April 2022

	Abstract	Full	Pdf
Apr 2020	2060	2041	1365
May 2020	2099	2088	1597
Jun 2020	932	920	531
Jul 2020	255	246	62
Aug 2020	231	223	74
Sep 2020	273	259	69
Oct 2020	356	335	100
Nov 2020	340	334	104
Dec 2020	422	402	58
Jan 2021	589	577	144
Feb 2021	416	378	136
Mar 2021	379	327	152
Apr 2021	248	221	110
May 2021	361	332	127
Jun 2021	281	266	71
Jul 2021	213	211	81
Aug 2021	249	238	83
Sep 2021	275	265	84
Oct 2021	269	249	111
Nov 2021	283	265	114
Dec 2021	230	230	98
Jan 2022	229	228	121
Feb 2022	236	238	112
Mar 2022	251	238	148
Apr 2022	223	214	101
Total	11700	11325	5753